The new proposed legislation, titled Patients Before Middlemen Act, looks to stop PBMs from being paid based on a drug’s list price.
“By tying administrative fees, rebate-based compensation, and other payments to a percentage of list price, current arrangements incentivize increases in sticker prices, harming patients at the pharmacy counter,” said a June 14 news release from the Senate Committee on Finance.
If passed, the act would require PBMs to pay excess designated service fees to the secretary of state.
